Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07284433 |
| Title | Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies (QUADvance) |
| Acronym | QUADvance |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | AvenCell Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Universitatsklinikum Ulm | NOT_YET_RECRUITING | Ulm | Baden-Wurttemberg | 89081 | Germany | Details |
| Universitaetsklinikum Erlangen | NOT_YET_RECRUITING | Erlangen | Bavaria | 91054 | Germany | Details |
| Klinikum der Universität München | NOT_YET_RECRUITING | Munich | Bavaria | 81377 | Germany | Details |
| Universitätsklinikum Marburg | NOT_YET_RECRUITING | Marburg | Hesse | 35032 | Germany | Details |
| Universitätsklinikum Dresden | RECRUITING | Dresden | Saxony | 01307 | Germany | Details |
| Charité Universitätsmedizin Berlin | RECRUITING | Berlin | 13353 | Germany | Details |